A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
Top Cited Papers
- 28 February 2009
- journal article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 10 (2), 125-134
- https://doi.org/10.1016/s1470-2045(08)70339-5
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cellsBlood, 2009
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Blood, 2008
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007
- Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)Blood, 2006
- Bias in the estimation of false discovery rate in microarray studiesBioinformatics, 2005
- Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemiaBritish Journal of Haematology, 2005
- Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarraysLeukemia, 2004
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- The majority of myeloid‐antigen‐positive (My+) childhood B‐cell precursor acute lymphoblastic leukaemias express TEL‐AML1 fusion transcriptsBritish Journal of Haematology, 1997
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958